Best practices in laboratory culture management often include cryopreservation of microbiota, but 21 this can be challenging with some virus particles. By preserving viral isolates researchers can mitigate 22 genetic drift and laboratory-induced selection, thereby maintaining genetically consistent strains between 23 experiments. To this end, we developed a method to cryopreserve the model, green-alga infecting virus, 24 Paramecium bursaria Chlorella virus 1 (PBCV-1). We explored cryotolerance of the infectivity of this virus 25 particle, whereby freezing without cryoprotectants was found to maintain the highest infectivity (~2.5%).
127 one year (Fig 1) . Seeing room for improvement, we tested the cryo-potential of PBCV-1 in an infected, cell-128 associated state. 
135
The PBCV-1 replication cycle requires about 6-8 h to release nascent virus particles (34). Post-136 infection sampling times for cryopreservation (10, 30, 60, 120, 180, 240, 300, 360 min PI) followed similar 137 sampling strategies used in PBCV-1 transcription studies (22, 23) . Specifically, these time points were 138 collected across distinct physiological phases in the PBCV-1 lifecycle and thus represent likely unique 139 conditions for cryopreservation. Following 24-h storage of cryopreserved, infected cells, we found that late 140 stages of infection were more conducive to virus survival than early stages ( Fig 2) . Thus, we followed cryo-141 stability for one year in one early (10 min PI) and two late infection stages (180 and 240 min PI) ( Fig 3) .
142 Small day-to-day fluctuations in virus titers were common, but were typically consistent among treatments, 143 suggesting human error. Despite these fluctuations, the lysate control, 180-min, and 240-min PI treatment 144 yielded an acceptable relative standard deviation (RSD) across all recovery assessments, indicating cryo-145 stability (Table 1) . Cryo-stability was not observed in the 10 min PI samples (Table 1) . In comparison to 146 virus lysate cryopreservation, the cell-associated method yielded significant improvement in survivorship 147 for the optimal 240-minute treatment (24.9 -30.1 fold increases). 
218
The general classification of cryoprotectants based on membrane permeability is consistent in the 219 infected cell treatment. Although the C. variabilis NC64A genome encodes a secondary active transporter 220 for the uptake of proline, radio-labeled solute uptake experiments revealed that PBCV-1 infection abolishes 221 its activity (48). With that in mind, the tonicity of the cryoprotectant mixture would equate to ~90 222 mOsmoles/L, as only DMSO and ethylene glycol are penetrating, and many of the components in the 223 MBBM media would be spent by late-logarithmic growth. This concentration is comparable to buffers 224 routinely used in our lab for handling C. variabilis (40 mOsmoles/L), so there is little concern of osmotic 225 stress. The chances of osmotic stress were also low considering the consistent success associated with this 226 cryopreservation formula across eukaryotic algae, including two Chlorella spp. (29). Our results are likely 227 applicable to any algal virus whose host can be cryopreserved. That said, we expect that researchers may 228 still have to adjust their cryoprotectant mixture to account for system differences related to osmolarity 229 tolerance and cryoprotectant toxicity. There has also been research indicating that axenicity impacts 230 cryopreservation survival in microalgae. In this light, it is possible that the bacterial community produces 231 secondary metabolites which promote survival (49). In another scenario, organisms with psychrophilic 232 tendencies might be adapted to freeze situations and cryoprotectant additives may not be necessary.
233
The goal of this study was to develop a long-term cryopreservation method for chlorovirus PBCV-234 1, but there are also interesting ecological implications of this research. Recent metagenomic and isolation 235 efforts indicate that giant viruses of microeukaryotes (e.g., Phycodnaviridae and Mimiviridae) are widely 236 distributed in nature (50, 51), but it is not well understood how these viruses persist in the environment.
237 Freezing events represent a potential mechanism of inactivation for some algal viruses, though chlorovirus 238 ATCV-1 is stable during these conditions (19) . In two other studies, a closely related giant virus of the 239 family Mimiviridae (52), as well as a second giant virus in the family Molliviridae (53), were revived from 240 30,000 year old permafrost. Both of these viruses were revived using Acanthamoeba spp., one of the main 241 hosts for many giant viruses. That said, there have been questions about whether Acanathamoeba and other 242 protists used for laboratory viral propagation are the natural or primary hosts of these ancient viruses (54).
243 Although these viruses might be able to withstand freezing temperatures on their own, the results of this 244 study suggest that a natural host might serve as a better vehicle for surviving freezing. Indeed, many 245 microbes produce natural cryoprotectants (e.g. L-proline, trehalose, betatine, etc.) or encode machinery to 246 transport these osmoprotectants into the cell. Following this thought process, it is possible that 247 environments containing frozen, infected cells might contain naturally cryopreserved algal-virus systems.
248 These systems may be deciphered following advances in single-cell sorting and sequencing techniques.
249 Indeed, a similar approach has been successfully utilized to identify and sequence single virus genomes in 250 the ocean (55). Though this latter study sorted virus particles, flow-cytometry sorting of viral infected cells 251 may be achieved using fluorescent probes specific for viral marker genes (e.g., major capsid protein) or dyes 252 to detect viral-induced host phenotypes (e.g., membrane blebbing). As a proof of concept, viral genetic 253 sequences from Siberian permafrost could be used to probe for still frozen viral-infected host cells, thereby 254 testing the natural host range of these viruses.
255
To our knowledge, this is the first report of successful cryopreservation of a eukaryotic algal virus 256 during its infection cycle. We expect that respective cellular hosts will provide more suitable physiological 257 conditions for cryopreservation and storage of algal viruses that infect eukaryotic algae. We also 258 recommend that laboratories working with algal viruses establish cryopreserved seed-stock systems to 259 better preserve wild-type controls for future experimentation, especially in lieu of future modification of 260 these viral systems.
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